Soliton, Inc. (SOLY)
| Market Cap | 487.65M |
| Revenue (ttm) | 370,000 |
| Net Income (ttm) | -17.88M |
| Shares Out | 21.60M |
| EPS (ttm) | -0.84 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,347,169 |
| Open | 22.56 |
| Previous Close | 22.55 |
| Day's Range | 22.56 - 22.59 |
| 52-Week Range | 7.40 - 22.60 |
| Beta | 0.18 |
| Analysts | Hold |
| Price Target | 22.60 (+0.1%) |
| Earnings Date | Nov 18, 2021 |
About SOLY
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas.
Financial Performance
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for Soliton stock is "Hold." The 12-month stock price forecast is 22.60, which is an increase of 0.09% from the latest price.
News
Allergan Aesthetics Completes Acquisition of Soliton
IRVINE, Calif., Dec. 16, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the successful completion of its acquisition of Soliton, Inc. (NASDAQ: SOLY).
Why Soliton Popped While the Market Slid Today
The company's absorption into AbbVie will apparently occur very, very soon.
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ONEM, SYKE, NETE, CHMA, SOLY, ARPO; Shareholders are Encouraged to...
NEW YORK , July 10, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: 1Life Healthcare, Inc. (NASDAQ: ONEM) concerning pot...
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Soliton, Inc. - SOLY
NEW YORK, May 15, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action ...
Soliton (SOLY) is in Overbought Territory: What's Next?
Soliton (SOLY) has moved higher as of late, but there could definitely be trouble on the horizon for this company
SOLITON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of P...
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Soliton, Inc. (Nas...
Soliton Reports First Quarter 2021 Results
HOUSTON, May 12, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial resu...
Shareholder Alert: Ademi LLP investigates whether Soliton, Inc. has obtained a Fair Price in its transaction with AbbVie
MILWAUKEE, May 10, 2021 /PRNewswire/ -- Ademi LLP is investigating Soliton (NASDAQ: SOLY) for possible breaches of fiduciary duty and other violations of law in its transaction with AbbVie. Click here t...
SHAREHOLDER ALERT: WeissLaw LLP Investigates Soliton, Inc.
NEW YORK, May 10, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Soliton, Inc. ("Soliton" or the "Company...
Soliton Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Soliton, Inc. Is Fair...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Soliton, Inc. (NASDAQ: SOLY) to Allergan Aesthetics for $22.60 per share in cash is f...
Soliton Stock Rallies After $22.60/Share Buyout From AbbVie
AbbVie Inc (NYSE: ABBV) is making an opportunistic play to boost the aesthetics business by adding a long-delayed body sculpting product into the fold. AbbVie's Allergan Aesthetics unit will pay $550 mi...
Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio
IRVINE, Calif. and HOUSTON, May 10, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV) and Soliton (NASDAQ: SOLY) today announced a definitive agreement under which Allergan Aesthe...
Introducing RESONIC™
HOUSTON, May 5, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the ...
Soliton to Report First Quarter 2021 Financial Results on May 13, 2021
HOUSTON, May 4, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the Compa...
Soliton Receives FDA Clearance of Special 510(k)
HOUSTON, April 29, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the U.S. Fo...
Soliton Announces Oral Presentation at American Society for Laser Medicine and Surgery Virtual Annual Conference
HOUSTON, April 27, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the 52...
Soliton Provides Special 510(k) and Commercialization Update
HOUSTON, April 15, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the U....
Soliton to Participate in Three Upcoming Healthcare Conferences
HOUSTON, March 11, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced members of ...
Soliton Announces Initiation of Second Animal Study for Potential RAP Treatment of Liver Fibrosis
HOUSTON, March 9, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced th...
Soliton Reports Fourth Quarter and Full Year 2020 Results
HOUSTON, March 4, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial res...
Soliton to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
HOUSTON, Feb. 22, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the Com...
Soliton Named Best New Technology Award at the Aesthetic Industry Association Board Meeting
HOUSTON, Feb. 18, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the com...
Soliton Announces FDA Clearance of Rapid Acoustic Pulse Technology for Use in Cellulite
HOUSTON, Feb. 1, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced tha...
Soliton Announces Collaboration with US Navy to Conduct Proof-of-Concept Study for Fibrotic Scars
HOUSTON, Jan. 26, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced it has enter...
Soliton Appoints Sean J. Shapiro as Vice President of Sales
HOUSTON, Dec. 30, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the appointm...